The Center for Science in the Public Interest has called on the Food and Drug Administration to ban the sale of high potency caffeine products to consumers. Despite FDA’s warning letters of last year, the products are still widely for sale, CSPI said.
The US Food and Drug Administration tells NutraIngredients-USA that it looks forward to learning more about the Council for Responsible Nutrition’s proposed industry-wide dietary supplement product registry.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is alarmed that FDA has taken so long to act against manufacturers of supplements containing methylsynephrine / oxilofrine.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is seeking a comprehensive list of enforcement actions taken by the Department of Justice related to the dietary supplement industry.
Scott Bass, partner, Sidley Austin LLP, and Steve Mister, President & CEO of the Council for Responsible Nutrition (CRN), will co-chair the Fourth Annual Legal, Regulatory, and Compliance Forum on Dietary Supplements.
With increasing pressure on the issue of supply chain management in the supplements business, how do traditional wildcrafting operations respond? For Don Stock, CEO of American Botanicals, the answer is to apply manufacturing process controls more common...
The Natural Products Association will change some bylaws as a result of its current legal issues, CEO Dan Fabricant told reporters in a conference call yesterday. Fabricant said he is confident the two lawsuits the group is involved in will resolved in...
The principal of a series of New Jersey-based dietary ingredient companies has pleaded guilty in connection with the sale of methamphetamine precursor chemicals, a separate scheme to defraud purchasers of dietary supplements and money laundering.
Dr. Robert Califf, President Obama’s nominee, has been confirmed to be the new FDA commissioner, and several supplement industry trade associations are trying to schedule a meeting with him as soon as possible.
A recent move by the Food and Drug Administration to detain products without examination from foreign firms that have failed GMP inspections is welcome step toward "draining the swamp," said United Natural Products Alliance president Loren...
The US Food and Drug Administration has announced the creation of the Office of Dietary Supplement Programs (ODSP), elevating the program from its previous status as a division under the Office of Nutrition Labeling and Dietary Supplements.
A Livingston, MT resident has been sentenced to four months in prison and ordered to pay $80,000 in liquidated damages after pleading guilty to selling dietary supplements in violation of two court orders.
Dietary supplement trade associations have universally welcomed the Department of Justice’s nationwide sweep targeting more than 100 makers and marketers of dietary supplements for alleged fraudulent ingredients and illegal claims.
The Department of Justice announced a criminal indictment of sports supplement maker USPLabs and several of its executives at a news conference in Washington, DC today as part of a nationwide sweep targeting more than 100 makers and marketers of dietary...
Attention from State Attorneys General is expected to continue and even increase, with a recent meeting of the National Association of Attorneys General’s in St Louis hosting a public session on herbal supplements.
Former FDA official Dr Joshua Sharfstein, MD, has proposed a new paradigm for the regulation of dietary supplements. The underlying shift would be a move from an attitude of “benefit versus risk” to one of “access with safety.”
Two cases of drug spiking in products purporting to be dietary supplements drew enforcement actions announced recently by the Food and Drug Administration. One case in Puerto Rico involves sex enhancement products, while another in Pennsylvania dealt...
The recent Bayer victory in its case with the FTC is a positive for industry, but it is not going to solve all of the industry’s FTC problems, says Dr Daniel Fabricant, CEO and Executive Director of the Natural Products Association.
The recent decision in the Bayer vs FTC case contains positive lessons and some points of caution for the industry, notably around what you need to substantiate claims and why FTC is not going away, says Steve Mister, President and CEO of the CRN.
The Bayer vs FTC case in the US District Court of New Jersey is full of lessons, including what does and does not constitute ‘competent and reliable scientific evidence’, and the importance of having experts who know the space.
UPDATED: NPA calls decision a "win for the industry and consumers"